Skip to main content
Login
Contact
Subscribe
Search form
Search
The Borger News-Herald
Home
Forms
News
Sports
Obituaries
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Photos
Videos
Games
Entertainment
Calendar
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Astellas Pharma Inc
(OP:
ALPMY
)
15.95
USD
+0.07 (+0.44%)
Streaming Delayed Price
Updated: 3:59 PM EST, Jan 19, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Astellas Pharma Inc
< Previous
1
2
3
Next >
Where Will Pfizer Be in 5 Years?
Today 8:53 EST
What's in store for America's biggest pharmaceutical company and its shareholders?
Tags
MYOV
ALPMY
VTRS
From
Motley Fool
The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Data, Sorrento To Buy R&D Partner, Kymera IPO
August 21, 2020
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 20) 10X Genomics Inc (NASDAQ: TXG) Avenue Therapeutics ...
Tags
Penny Stocks
General
GMAB
From
Benzinga
Will Johnson & Johnson Acquire Arrowhead Pharmaceuticals?
June 02, 2020
Will the pharma giant be interested in acquiring a mid-cap partner with a promising treatment for hepatitis B?
Tags
JNJ
ARWR
Market News
From
Motley Fool
The Daily Biotech Pulse: Cumberland's Positive Anti-Bacterial Readout, FDA Nods For Bristol-Myers, Astellas
May 27, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
TRIB
MEIP
Market News
From
Benzinga
The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive
May 21, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ...
Tags
AQST
SYBX
NVO
From
Benzinga
Stocks That Hit 52-Week Highs On Tuesday
March 24, 2020
This morning 1422 companies reached new 52-week highs. Noteworthy Mentions: Tencent Holdings(OTC: TCTZF)was the ...
Tags
TNTRQ
LBRMF
EONGY
From
Benzinga
The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test
March 24, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit ...
Tags
IMV
PEN
NVCN
From
Benzinga
FibroGen's Anemia Drug Goes to FDA for Review
February 12, 2020
A decision on Roxadustat should arrive by Dec. 20.
Tags
ALPMY
AZN
FGEN
From
Motley Fool
Seattle Genetics, Astellas, and Merck Hit a Bladder Cancer Bullseye
February 11, 2020
Seattle Genetics posted eye-popping data from a study of patients given a combination of Padcev and Keytruda.
Tags
ALPMY
Market News
MRK
From
Motley Fool
Stocks That Hit 52-Week Highs On Tuesday
February 11, 2020
Before 10 a.m. ET Tuesday, 411 stocks made new 52-week highs. Interesting Highlights: Microsoft(NASDAQ: MSFT)was ...
Tags
AQN
GPN
BYD
From
Benzinga
The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology
February 11, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
GALT
ASND
DXCM
From
Benzinga
Stocks That Hit 52-Week Highs On Monday
February 10, 2020
On Monday morning, 192 companies achieved new highs for the year. Areas of Interest: Microsoft(NASDAQ: MSFT)was the ...
Tags
VGI
BLU
Industrials
From
Benzinga
Stocks That Hit 52-Week Highs On Thursday
February 06, 2020
During Thursday's morning session, 296 companies made new 52-week highs. Facts of Interest: Johnson & ...
Tags
ITOCY
FLT
MRGE
From
Benzinga
Amgen Is Making 3 Big Bets -- Will They Pay Off for Investors?
February 02, 2020
At least one of these bets is already looking like a smart move.
Tags
Market News
BGNE
AZN
From
Motley Fool
Stocks That Hit 52-Week Highs On Friday
January 31, 2020
Friday's morning session saw 152 companies set new 52-week highs. Interesting Highlights: Amazon.com(NASDAQ: ...
Tags
AWK
SHOP
HR
From
Benzinga
The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance
January 30, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
ALXN
APTO
WST
From
Benzinga
The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance
January 15, 2020
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ...
Tags
RVNC
ARVN
MYOK
From
Benzinga
Why Adaptimmune Therapeutics Is Jumping 11.5% Today
January 14, 2020
The clinical-stage company has inked a new deal with a big biopharma.
Tags
ALPMY
ADAP
Market News
From
Motley Fool
The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug
January 14, 2020
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that ...
Tags
ANIX
HZNP
ACST
From
Benzinga
The Daily Biotech Pulse: Flexion Receives FDA Nod For Zilretta Label Expansion, Astellas Goes Shopping
December 27, 2019
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech ...
Tags
XOMA
M&A
KPTI
From
Benzinga
A Perspective On Biopharma's Record M&A Run In 2019
December 23, 2019
This year was a watershed one for biopharma M&A, with several multibillion-dollar deals announced thus far. M&A activity in ...
Tags
Media
VRTX
CRSP
From
Benzinga
Seattle Genetics Drug For Difficult-To-Treat Urothelial Cancer Gets Early FDA Nod
December 19, 2019
Seattle Genetics, Inc. (NASDAQ: SGEN) shares are advancing following an early approval for Padcev, an antibody conjugate therapy it is ...
Tags
Biotech
Bank of America
ALPMY
From
Benzinga
The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For Antibiotic
December 19, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ...
Tags
NERV
SRPT
PRTK
From
Benzinga
The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO
December 17, 2019
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that ...
Tags
M&A
AGIO
CUE
From
Benzinga
There’s more upside for biotech even after 24% gains in two months
December 12, 2019
Seven biotech stocks to consider buying.
Tags
BOLD
Opinion
ARQL
From
MarketWatch
Stocks That Hit 52-Week Highs On Friday
December 06, 2019
This morning 257 companies set new 52-week highs. Significant Points: The largest company by market cap to set a new 52-week ...
Tags
JPM
BIF
ITRI
From
Benzinga
The Daily Biotech Pulse: Roche's Tecentriq Snags FDA Nod For Lung Cancer, Rapt Out-Licenses Cancer Drug
December 04, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ...
Tags
DRNA
News
FDA
From
Benzinga
Here's Why uniQure Is Rallying 13% Today
December 03, 2019
Investor optimism is surging following recent M&A in gene therapy.
Tags
ALPMY
ONCE
Market News
From
Motley Fool
The Gene Therapy Names Moving On The Audentes Buyout Deal
December 03, 2019
Gene therapy company Audentes Therapeutics Inc (NASDAQ: BOLD) announced a deal late Monday to be acquired by Japanese pharma company ...
Tags
Top Stories
RHHBY
ONCE
From
Benzinga
PreMarket Prep Recap: Red On The Screen And Looking For More
December 03, 2019
With a sea of red engulfing the markets Tuesday morning, there was plenty to discuss on thePreMarket Prep Show. When Red Is Not ...
Tags
ALPMY
Technicals
Long Ideas
From
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.